Cargando…
Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection
We previously showed that in mice infected with Leishmania major type I interferons (IFNs) initiate the innate immune response to the parasite at day 1 and 2 of infection. Here, we investigated which type I IFN subtypes are expressed during the first 8 weeks of L. major infection and whether type I...
Autores principales: | Schleicher, Ulrike, Liese, Jan, Justies, Nicole, Mischke, Thomas, Haeberlein, Simone, Sebald, Heidi, Kalinke, Ulrich, Weiss, Siegfried, Bogdan, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807663/ https://www.ncbi.nlm.nih.gov/pubmed/29459858 http://dx.doi.org/10.3389/fimmu.2018.00079 |
Ejemplares similares
-
IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo
por: Haeberlein, Simone, et al.
Publicado: (2010) -
Dendritic Cells Are Responsible for the Capacity of CpG Oligodeoxynucleotides to Act as an Adjuvant for Protective Vaccine Immunity Against Leishmania major in Mice
por: Shah, Javeed A., et al.
Publicado: (2003) -
Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites
por: Messlinger, Helena, et al.
Publicado: (2018) -
Recombinant interleukin 12 cures mice infected with Leishmania major
Publicado: (1993) -
Methylation Profiles of CpG Island Loci in Major Types of Human Cancers
por: Park, Seog-Yun, et al.
Publicado: (2007)